Flare and Merck Partner to Advance FX-909 Combo in Cancer
CAMBRIDGE, MA – October 21, 2025 – Flare Therapeutics Inc. (FlareTx), a clinical-stage biotechnology company pioneering therapies that target...
Advertisement
Healthy Paws, Airvet Partner to Expand Nationwide Pet Telehealth
NEW YORK, October 20, 2025 Healthy Paws, a Chubb company and a leading provider of pet health insurance, has...
Arrowhead Pharma and Novartis Advance RNAi Therapy for Parkinson’s
Pasadena, CA – October 21, 2025 – Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) has officially completed its global licensing and...
FDA Approves TEZSPIRE for Chronic Rhinosinusitis with Nasal Polyps
THOUSAND OAKS, Calif., October 17, 2025 — In a landmark regulatory decision, the U.S. Food and Drug Administration (FDA)...
BrainBox TBI Study Reveals Breakthrough in Concussion Diagnosis
RICHMOND, VA – October 17, 2025: BrainBox Solutions has published a major analysis in JAMA Network OPEN from its...
Boston Scientific to Acquire Nalu Medical for Pain Therapy Expansion
Marlborough, MA – October 17, 2025 – Boston Scientific Corporation announced that it has entered into a definitive agreement...
Praxis Secures $525M to Boost CNS Drug Development
BOSTON, October 16, 2025 Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company, has announced the successful pricing...
Celltrion Gains FDA Nod for YUFLYMA Pediatric Use Expansion
Incheon, South Korea – October 16, 2025 – CelltrionUSA, a subsidiary of Celltrion Inc., announced that the U.S. Food...
AB Science Secures €2.8 Million in Private Placement to Advance Clinical Pipeline
PARIS, October 17, 2025 AB Science S.A., a biopharmaceutical company focused on discovering, developing, and marketing protein kinase inhibitors,...
FDA Fast Tracks Enterome’s OncoMimics™ Cancer Immunotherapy EO2463
Paris, France – October 16, 2025 – The U.S. Food and Drug Administration (FDA) has granted Fast Track designation...
Advertisement
